Skip to main content
HCONRES 225 108th Congress House Foreign Trade and International Finance Access to health care Canada Commerce Congress Consumer education Consumer protection Crime and Law Enforcement Crime prevention Drug approvals Drug industry Drugs Health Health care industry Health education Imports Legislation Medicare Prescription pricing Price discrimination

Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.

Introduced: June 19, 2003 Introduced by: Meeks, Gregory W. Democratic · New York See on congress.gov
Sign in to write a letter Sign in to watch
This resolution expired with the 108th Congress
It was not agreed to before the 108th Congress (2003–2004) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
Jun 24, 2003
Referred to the Subcommittee on Health.
Jun 23, 2003
Referred to the Subcommittee on Trade.
Jun 19, 2003
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 19, 2003
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Expresses the sense of Congress that: (1) the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers; (2) the President should take action to prevent the illegal importation of prescription drugs from Canada or any other foreign country; (3) the United States Trade Representative should take action to correct the inequities and discrimination caused by Canada's Patented Medicine Pricing Review Board; (4) the pharmaceutical industry and the health care community should work with United States consumers to lower the price of prescription drugs and should mount a nationwide educational awareness program regarding the dangers of imported drugs and medicines; and (5) Congress should enact a Medicare drug benefit as the best and safest way for United States patients to obtain their prescription drugs.
What's happening now June 24, 2003

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H. Con. Res. 225: Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.. 108th Congress. Open America. https://openamerica.io/bill/108-HCONRES-225/
MLA
"H. Con. Res. 225: Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HCONRES-225/.
Bluebook (legal)
H. Con. Res. 225, 108th Cong. (2026), https://openamerica.io/bill/108-HCONRES-225/.
Markdown link
[H. Con. Res. 225: Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.](https://openamerica.io/bill/108-HCONRES-225/)
Report a problem